Description

For over a quarter-century, this actively managed portfolio has offered investors an economical gateway to companies worldwide operating within the healthcare sector. Its holdings encompass pharmaceutical giants, medical equipment manufacturers, and cutting-edge research organizations. Compared to its peers in the healthcare space, this fund typically exhibits broader international exposure and a lower portfolio turnover rate. Nevertheless, investors should acknowledge the inherent concentration risk, as it exclusively targets the health care industry. Given that annual returns can fluctuate significantly, this fund is best suited as a supplementary component within a well-diversified investment strategy, particularly for those with a lengthy time horizon.